Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Three Stocks That May Be Undervalued In November 2024

In This Article:

As global markets navigate the uncertainties introduced by the incoming Trump administration, investors are keenly observing shifts in sector performance and policy impacts. With U.S. stocks retracting some gains amid these developments, identifying undervalued opportunities becomes crucial for those looking to capitalize on market fluctuations. In this context, a good stock may be one that demonstrates resilience or potential for growth despite current market volatility and policy changes.

Top 10 Undervalued Stocks Based On Cash Flows

Name

Current Price

Fair Value (Est)

Discount (Est)

Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016)

CN¥16.71

CN¥33.16

49.6%

Tibet Rhodiola Pharmaceutical Holding (SHSE:600211)

CN¥38.49

CN¥76.93

50%

Taiwan Union Technology (TPEX:6274)

NT$156.50

NT$311.70

49.8%

Wuhan Keqian BiologyLtd (SHSE:688526)

CN¥14.57

CN¥29.09

49.9%

ConvaTec Group (LSE:CTEC)

£2.43

£4.85

49.9%

TF Bank (OM:TFBANK)

SEK312.00

SEK621.04

49.8%

AirBoss of America (TSX:BOS)

CA$4.23

CA$8.40

49.6%

Saipem (BIT:SPM)

€2.342

€4.65

49.6%

Intellian Technologies (KOSDAQ:A189300)

₩44450.00

₩88893.31

50%

Nokian Renkaat Oyj (HLSE:TYRES)

€7.408

€14.72

49.7%

Click here to see the full list of 935 stocks from our Undervalued Stocks Based On Cash Flows screener.

Underneath we present a selection of stocks filtered out by our screen.

Solvay

Overview: Solvay SA is a global provider of advanced materials and specialty chemicals, with a market cap of €3.33 billion.

Operations: The company's revenue is derived from Basic Chemicals (€3.23 billion), Performance Chemicals (€2.02 billion), and Corporate & Business Services (€130 million).

Estimated Discount To Fair Value: 43.3%

Solvay appears undervalued, trading at €31.92, significantly below its estimated fair value of €56.27. Despite recent earnings challenges—such as a drop in net income to €19 million for Q3 2024 from €220 million the previous year—the company's forecasted high return on equity and expected profitability within three years highlight potential long-term value. However, its high debt levels and volatile share price warrant cautious consideration for investors focusing on cash flow valuation metrics.

ENXTBR:SOLB Discounted Cash Flow as at Nov 2024
ENXTBR:SOLB Discounted Cash Flow as at Nov 2024

Dongsung FineTec

Overview: Dongsung FineTec Co., Ltd. manufactures and sells cryogenic insulation products in South Korea, with a market cap of ₩369.88 billion.

Operations: The company's revenue segments include the Gas Business, generating ₩22.17 billion, and Cooling Material, contributing ₩516.27 billion.